Sudden death prevention in patients with advanced ventricular dysfunction.
about
Chronic kidney disease and risk factors responsible for sudden cardiac death: a whiff of hope?Ion Channels in the HeartMechanisms of altered Ca²⁺ handling in heart failureNew therapeutic targets in cardiology: arrhythmias and Ca2+/calmodulin-dependent kinase II (CaMKII)Antithrombotic therapy for congestive heart failureAntithrombotic therapy in patients with chronic heart failure: rationale, clinical evidence and practical implicationsVentricular arrhythmias in congestive heart failure: clinical significance and managementPreventing sudden death after repair of tetralogy of Fallot: complex therapy for complex patients.Prevalence of QT prolongation and associated LVEF changes in diabetic patients over a four-year retrospective time periodFacts and principles learned at the 31st Annual Williamsburg Conference on Heart Disease.Treatment of arrhythmias in heart failure.QTc interval prolongation predicts postoperative mortality in heart failure patients undergoing surgical revascularization.Selective knockout of mouse ERG1 B potassium channel eliminates I(Kr) in adult ventricular myocytes and elicits episodes of abrupt sinus bradycardia.Upregulation of adenosine A1 receptors facilitates sinoatrial node dysfunction in chronic canine heart failure by exacerbating nodal conduction abnormalities revealed by novel dual-sided intramural optical mappingObservational cohort study of ventricular arrhythmia in adults with Marfan syndrome caused by FBN1 mutations.Strategies for the prevention and treatment of sudden cardiac death.Oxidized CaMKII causes cardiac sinus node dysfunction in mice.QRS duration: a simple marker for predicting cardiac mortality in ICD patients with heart failureGenetic Polymorphisms as Risk Stratification Tool in Primary Preventive ICD Therapy.Epidemiology and genetics of sudden cardiac deathDrug and drug-device therapy in heart failure patients in the post-COMET and SCD-HeFT era.Mechanisms of ventricular arrhythmias in heart failure.CKD and sudden cardiac death: epidemiology, mechanisms, and therapeutic approaches.Mechanisms of arrhythmias and conduction disorders in older adults.Long-term follow up of patients with implantable cardioverter-defibrillators and mild, moderate, or severe impairment of left ventricular functionThe spectrum of epidemiology underlying sudden cardiac death.Primary prevention of sudden cardiac death using implantable cardioverter defibrillators.Molecular correlates of altered expression of potassium currents in failing rabbit myocardium.'And the beat goes on.' The cardiac conduction system: the wiring system of the heart.Heart failure modulates electropharmacological characteristics of sinoatrial nodes.Tachycardia-bradycardia syndrome: Electrophysiological mechanisms and future therapeutic approaches (Review).What is the risk of hyperkalaemia in heart failure?New paradigms in the prevention of sudden cardiac arrest and heart failure treatment.Immunometabolic role of long-chain omega-3 fatty acids in obesity-induced inflammation.Long-chain omega-3 fatty acids: time to establish a dietary reference intake.How to recognize epicardial origin of ventricular tachycardias?Dual gene therapy with SERCA1 and Kir2.1 abbreviates excitation without suppressing contractility.Heart acceleration and deceleration capacities associated with dilated cardiomyopathy.Heart rate variability in left ventricular dysfunction and heart failure: effects and implications of drug treatment.Renal sympathetic denervation guided by renal nerve stimulation to treat ventricular arrhythmia in CKD patients with ICD.
P2860
Q26748992-B9032AA0-974C-4F3E-AC50-9CF680A22E01Q26829681-2C9C9AE6-7013-493D-A01D-A026B18407CAQ27012758-78382664-8CC2-477B-97E3-E193689961B1Q27016402-015FC93E-1609-4DE5-80F4-D561C2925FF9Q28194472-846283DF-3582-4F96-8C1C-BC115C945A25Q28201185-907D631B-0B85-475C-B1D3-F9CF503201D8Q33144673-88D50248-A8BB-40A5-BFA7-877A8B50010DQ33750149-933C203E-74B5-4F76-B4F8-603040ED7E21Q33806055-7E945C24-91C2-4111-8EA2-EA3858CBF313Q33944878-51D0228C-0B63-4FDB-B701-957FABA606A0Q33999701-9588D3E4-5603-4238-9F8E-6142BAD67A94Q34478424-78B7D111-1BD4-47A9-9046-2FE8ED53233BQ34739701-2E6D5669-850A-4DBB-B7CF-7565FD4B0E31Q35068578-9B3C0506-EBD6-4AC7-9B94-A53C60412509Q35069518-8E1B0FA7-60EB-469F-9C95-D34998DC6C09Q35560103-459D5183-CE26-4C25-9DD1-FA3693B01217Q35572691-C79F6C24-9AC6-4015-99D4-AA29400071B2Q35581680-40B13CC7-A965-4E0A-994A-50399813A88BQ35684262-E9025722-101E-427F-BA75-4A25FB2923C0Q36102464-567189E3-5249-4AEA-91F5-6C6690C8D0ECQ36167689-E4BBA775-0786-4993-A325-6A2842FC4A7AQ36247459-48BF7FE8-243F-4C00-95CC-8B89D8051172Q36426077-2F9E5965-443F-465F-8BDB-C5C1DE9CA8F9Q36723709-85031F5F-9A32-45B2-A6C7-797E50A56520Q36847784-8CC06FA6-3602-4129-8A49-145420C10AD4Q37057557-B91DDFDA-0A68-40B8-B3A4-7BFCB36E25AEQ37193184-9B7741D5-B8E5-4CFD-8558-35E96475D8D4Q37264873-B1C5DA69-1864-496B-AF13-6588D19B5337Q37547650-DC1FDB00-5294-4B32-8B3B-6C0DE31B442CQ37697674-7D1BD92A-859D-4A46-8927-F1D25003FE18Q37713991-D1309073-0C3D-43C9-9A72-B6A551EFB2BEQ37902667-4D3C0DA4-1869-4085-B407-0383C272C868Q37905685-CE437A8E-7224-4AD9-8FB0-D94C54FF58EBQ38099615-DBC03485-7EE9-40D7-B7AA-DF87BBCB080EQ38151841-74EA536E-8D1E-4949-A3B0-61878311605FQ38211720-78264007-5626-44F3-A805-8641260B8F62Q39737461-BCBDABDF-3671-4895-92FB-E1EBBAB6C6FFQ40072259-379C96A5-8B3A-4C0D-8DC8-C51891309768Q40594157-341F48AB-CEB1-4946-9E7C-C9298787C049Q41036358-A031DFBA-BAA3-4F15-9907-E6E6ACF9D1BC
P2860
Sudden death prevention in patients with advanced ventricular dysfunction.
description
1993 nî lūn-bûn
@nan
1993 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1993 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
1993年の論文
@ja
1993年論文
@yue
1993年論文
@zh-hant
1993年論文
@zh-hk
1993年論文
@zh-mo
1993年論文
@zh-tw
1993年论文
@wuu
name
Sudden death prevention in patients with advanced ventricular dysfunction.
@ast
Sudden death prevention in patients with advanced ventricular dysfunction.
@en
type
label
Sudden death prevention in patients with advanced ventricular dysfunction.
@ast
Sudden death prevention in patients with advanced ventricular dysfunction.
@en
prefLabel
Sudden death prevention in patients with advanced ventricular dysfunction.
@ast
Sudden death prevention in patients with advanced ventricular dysfunction.
@en
P2093
P356
P1433
P1476
Sudden death prevention in patients with advanced ventricular dysfunction.
@en
P2093
Middlekauff HR
Stevenson LW
Stevenson WG
P304
P356
10.1161/01.CIR.88.6.2953
P407
P577
1993-12-01T00:00:00Z